2014
DOI: 10.1016/j.autneu.2014.04.003
|View full text |Cite|
|
Sign up to set email alerts
|

Life threatening causes of syncope: Channelopathies and cardiomyopathies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 85 publications
0
3
0
Order By: Relevance
“…Patients with certain genetic diseases that causes abnormal function of the cardiac ion channels such as Brugada, prolonged QT, short QT or catecholaminergic polymorphic ventricular tachycardia are more susceptible to sudden cardiac death [ 23 ]. During asymptomatic periods, patients with QT changes or catecholaminergic polymorphic ventricular tachycardia will have normal ECGs and no underlying structural heart disease identified on echocardiography, which can make diagnosis difficult.…”
Section: Investigationsmentioning
confidence: 99%
“…Patients with certain genetic diseases that causes abnormal function of the cardiac ion channels such as Brugada, prolonged QT, short QT or catecholaminergic polymorphic ventricular tachycardia are more susceptible to sudden cardiac death [ 23 ]. During asymptomatic periods, patients with QT changes or catecholaminergic polymorphic ventricular tachycardia will have normal ECGs and no underlying structural heart disease identified on echocardiography, which can make diagnosis difficult.…”
Section: Investigationsmentioning
confidence: 99%
“…ARVC (3) CPVT (1) five patients (16%) experienced ATP (median time 1.04 years) and 15 patients (10%) experienced both a shock and ATP. The overall rate of experiencing any appropriate therapy (ATP or shock) in ICD recipients was 0.16 per year (SEM=0.14).…”
Section: Genetic Testing N=4mentioning
confidence: 99%
“…Genetic causes are found in various potentially lethal channelopathies and cardiomyopathies including long and short QT syndrome (LQTS and SQTS), Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia (CPVT), hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmogenic right ventricular dysplasia/ cardiomyopathy (ARVD/C), Barth syndrome, and left ventricular non-compaction. 1 Knowledge of genetics deepens the understanding of pathophysiology and remarkably changes the diagnosis, treatment, and genetic counselling for recurrence risk and family planning. This group is highly genetically heterogeneous ( Table 1 2 ).…”
Section: Introductionmentioning
confidence: 99%